Know Cancer

or
forgot password

Supporting Patient Provider Communication for Children With Cancer and Congenital Heart Disease


N/A
7 Years
12 Years
Open (Enrolling)
Both
Cancer, Congenital Heart Disease

Thank you

Trial Information

Supporting Patient Provider Communication for Children With Cancer and Congenital Heart Disease


Inclusion Criteria:



- Between 7 and 12 years.

- Ethnic norwegian.

- Undergoing treatment for cancer or diagnosed with a congenital heart disease.

Exclusion Criteria:

- Receiving or have received radiation the brain as this may affect their abilities to
use SiSom and communicate during consultations.

- Syndromes, mental retardation, developmental disorders, language disorders, or
cognitive disorders that affect their ability to report symptoms or communicate
during consultations.

- Other ethnic origin.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Patient-provider communication

Outcome Time Frame:

Single measure, video recording of medical consultation lasting approximately one hour

Safety Issue:

No

Principal Investigator

Cornelia M Ruland, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Oslo University Hospital

Authority:

Norway:National Committee for Medical and Health Research Ethics

Study ID:

S-05288

NCT ID:

NCT01280227

Start Date:

January 2005

Completion Date:

February 2011

Related Keywords:

  • Cancer
  • Congenital Heart Disease
  • Symptom management
  • Symptom assessment
  • Patient satisfaction
  • Patient-provider communication
  • Heart Diseases
  • Heart Defects, Congenital

Name

Location